Aeolus Pharmaceuticl Stock Today
| AOLS Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 84
|
Aeolus Pharmaceuticl is selling for under 1.0E-4 as of the 30th of November 2024; that is No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Aeolus Pharmaceuticl has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Aeolus Pharmaceuticl are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California. The company has 152.09 M outstanding shares. More on Aeolus Pharmaceuticl
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Aeolus Pink Sheet Highlights
| CEO and Pres | John McManus |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Aeolus Pharmaceuticl [AOLS] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 167.29 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aeolus Pharmaceuticl's market, we take the total number of its shares issued and multiply it by Aeolus Pharmaceuticl's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aeolus Pharmaceuticl conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 152.09 M outstanding shares.
Aeolus Pharmaceuticl currently holds about 403 K in cash with (3.11 M) of positive cash flow from operations.
Check Aeolus Pharmaceuticl Probability Of Bankruptcy
Aeolus Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aeolus Pharmaceuticl without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Additional Tools for Aeolus Pink Sheet Analysis
When running Aeolus Pharmaceuticl's price analysis, check to measure Aeolus Pharmaceuticl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aeolus Pharmaceuticl is operating at the current time. Most of Aeolus Pharmaceuticl's value examination focuses on studying past and present price action to predict the probability of Aeolus Pharmaceuticl's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aeolus Pharmaceuticl's price. Additionally, you may evaluate how the addition of Aeolus Pharmaceuticl to your portfolios can decrease your overall portfolio volatility.